| 12:10-12:15 | 致辞 |
致辞 |
|
||||
| 12:15-12:40 | 专题会 |
尿路上皮癌HER2免疫组化检测临床病理专家共识(2026版)解读 |
|
||||
| 12:40-13:10 | 专题会 |
2025PQCC尿路上皮癌HER2免疫组化判读能力验证结果分析 |
|
||||
| 13:10-13:35 | 专题会 |
2025PQCC尿路上皮癌HER2免疫组化染色质控结果分析 |
|
||||
| 13:35-13:40 | 总结 |
总结 |
|
||||
| 14:00-14:10 | 致辞 |
致辞 |
|
||||||
| 14:10-14:40 | 专题报告 |
Extramedullary Plasmacytoma and Extramedullary Disease of Multiple Myeloma: A Comparative Molecular Analysis |
|
||||||
| 14:40-15:10 | 专题报告 |
From CLL to Richter syndrome: at the interface of Boolean network modeling and experimental readouts |
|
||||||
| 15:10-15:40 | 专题报告 |
Bone marrow fibrosis, causes and potential therapeutic targets |
|
||||||
| 15:40-16:10 | 专题报告 |
Precise Diagnosis and Risk Stratification of Extranodal NK/T-Cell Lymphoma |
|
||||||
| 16:10-16:20 | 讨论 |
讨论 |
|||||||
| 16:20-16:50 | 专题报告 |
EBV positive diffuse large B cell lymphoma |
|
||||
| 16:50-17:20 | 专题报告 |
Thyroid Lymphomas: Morphology, Molecules, and Mechanisms |
|
||||
| 17:20-17:50 | 专题报告 |
Pathological Diagnosis and Case Presentation of Castleman Disease |
|
||||
| 17:50-18:00 | 讨论 |
讨论 |
|||||